๐๏ธ Verified NIH Record โข Updated 2026-06-12
Effects of Novel E-cigarette Constituents on Adults TCORS 3.0 (NCT05932745)
Examining Appeal and Addiction Potential of Novel E-cigarette Constituents Among Adults
๐ข Recruiting Observational / Diagnostic ๐ Clinical Research Protocol Sponsor: Yale University
๐ฉบ Plain-English Summary (8th-Grade Level)
This study is an examination of the influence of cooling components of WS-3, WS-23, and menthol on the appeal and addiction potential of nicotine-containing e-liquids among adults.
Who can join: Review the eligibility criteria below.
Location: JB Pierce Lab โ New Haven, Connecticut
Age range: 18 Years
๐งช Interventions in This Study
- E-liquid coolant (No WS-3) for non-menthol (1) (OTHER)
- E-liquid coolant (No WS-3) for low (0.1%) menthol (1) (OTHER)
- E-liquid coolant (No WS-3) for high (2.0%) menthol (1) (OTHER)
- E-liquid coolant (Low [0.1%] WS-3) for non-menthol (2) (OTHER)
- E-liquid coolant (Low [0.1%] WS-3) for low (0.1%) menthol (2) (OTHER)
- E-liquid coolant (Low [0.1%] WS-3) for high (2.0%) menthol (2) (OTHER)
- E-liquid coolant (High [2.0%] WS-3) for non-menthol (3) (OTHER)
- E-liquid coolant (High [2.0%] WS-3) for low (0.1%) menthol (3) (OTHER)
- E-liquid coolant (High [2.0%] WS-3) for high (2.0%) menthol (3) (OTHER)
- E-liquid coolant (Low [0.1%] WS-23) for non-menthol (4) (OTHER)
- E-liquid coolant (Low [0.1%] WS-23) for low (0.1%) menthol (4) (OTHER)
- E-liquid coolant (Low [0.1%] WS-23) for high (2.0%) menthol (4) (OTHER)
- E-liquid coolant (High [2.0%] WS-23) for non-menthol (5) (OTHER)
- E-liquid coolant (High [2.0%] WS-23) for low (0.1%) menthol (5) (OTHER)
- E-liquid coolant (High [2.0%] WS-23) for high (2.0%) menthol (5) (OTHER)
- E-liquid coolant (4% WS-23) for non-menthol (6) (OTHER)
- E-liquid coolant (4% WS-23) for low (0.1%) menthol (6) (OTHER)
- E-liquid coolant (4% WS-23) for high (2.0%) menthol (6) (OTHER)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- JB Pierce Lab โ New Haven, Connecticut
๐ Contact the Study Coordinator
Phone: (203) 974-7607
Email: danielle.davis@yale.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Nicotine Use Disorder
- Identify the Optimal TMS Pulse Protocol to Modulate Reward Activity โ Newark, New Jersey
- Temporal Interference Methods for Addiction Treatment โ Bloomington, Indiana
- Identify the Optimal TMS Target to Modulate Reward Activity โ Newark, New Jersey
- Implementation of Tobacco Cessation Programming at Community Behavioral Health Sites โ Chicago, Illinois
Explore by condition: All Nicotine Use Disorder clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.